Upinder Singh, MD
Geriatric Medicine · Henderson, NVNPI 1609846229
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Eisai Inc. accounts for 79.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $5,131 and has fallen 90.3% since, to $499 in 2025. Among geriatric medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $221.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$6K
- Cipla USA Inc.$456
- AbbVie$260
- AstraZeneca$253
- Penumbra, Inc.$148
- Bayer$122
- plus $269 from 4 others
What the payments were for
- Consulting fees$1,08515%
- Speaking & faculty fees$3,56549%
- Travel & lodging$6379%
- Food & beverage$2,02528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 22 | $5,805 |
| Cipla USA Inc. | 1 | $456 |
| AbbVie | 2 | $260 |
| AstraZeneca | 2 | $253 |
| Penumbra, Inc. | 1 | $148 |
| Bayer | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 1 | $108 |
| Advanced Medical Administration | 1 | $71 |
| Livanova USA, Inc. | 1 | $67 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$5,629
- ZEMDRI (PLAZOMICIN)$456
- BREZTRI$253
- Skyrizi$149
- Indigo System$148
- Kerendia$122
- Seglentis$108
How this compares
$7,313 in reported general payments places this provider in the 95th percentile of 36 geriatric medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $17,110 |
| Memantine Hcl | 31 | $912 |
| Atorvastatin Calcium | 37 | $505 |
| Losartan Potassium | 16 | $346 |
| Celecoxib | 14 | $244 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $244 |
| Famotidine | 14 | $244 |
| Trazodone Hcl | 12 | $207 |
| Donepezil Hcl | 13 | $183 |
| Lisinopril | 15 | $153 |
| Metoprolol Tartrate | 15 | $136 |
| Levothyroxine Sodium | 15 | $121 |
| Pantoprazole Sodium | 14 | $112 |
| Escitalopram Oxalate | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Henderson
- Syed RahmanHenderson$339
- Peter TranHenderson$258
- Aurelio MuyotHenderson$12
- Julie Zacharias SimpsonHenderson$12
- Leonardo Gan-LimLas Vegas$10K
- Denver MillerSparks$7K
- Calvin VanrekenReno$5K
- Syed HussainLas Vegas$2K
- Alvin Bay LinLas Vegas$2K
- Sudheer PolisettyLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.